Back
NovoCure Vs. Spyre Therapeutics Industry Stock Comparison
Sell
32
NVCR
NovoCure
Last Price:
19.42
Seasonality Move:
15.72%
Sell
39
SYRE
Spyre Therapeutics
Last Price:
25.33
Seasonality Move:
49.76%
Sell
32
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $19.40. The Score for NVCR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $25.43. The Score for SYRE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVCR Stock Price Chart
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $25.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.68 | Buy |
Relative Strength Index (14 RSI): | 43.36 | Sell |
Chaikin Money Flow: | -1183540 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.6 - 23.24) | Sell |
Bollinger Bands (100): | (12.88 - 19.84) | Buy |
SYRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.04 | Sell |
Relative Strength Index (14 RSI): | 31.35 | Sell |
Chaikin Money Flow: | -1780910 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.05 - 37.75) | Sell |
Bollinger Bands (100): | (27.4 - 39.18) | Sell |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.26 | Sell |
20-day SMA: | 22.22 | Sell |
50-day SMA: | 17.77 | Buy |
200-day SMA: | 15.5 | Buy |
8-day EMA: | 21.16 | Sell |
20-day EMA: | 21.09 | Sell |
50-day EMA: | 19.03 | Buy |
200-day EMA: | 21.88 | Sell |
SYRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.63 | Sell |
20-day SMA: | 34.16 | Sell |
50-day SMA: | 35.1 | Sell |
200-day SMA: | 24.22 | Buy |
8-day EMA: | 32.34 | Sell |
20-day EMA: | 33.91 | Sell |
50-day EMA: | 34.32 | Sell |
200-day EMA: | 27.18 | Sell |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.00 per share, an increase this year of $0.42 per share, and a decrease next year of $0.11 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
NovoCure Technical Analysis
Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Spyre Therapeutics Technical Analysis
Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |